9.0/10 (17900 reviews)
zeelool.com has been visited by 10K+ users in the past month
Zeelool offers free PD measurement tools and provides professional fitting services. Try on new glasses with Zeelool's AR tool and see how you look in seconds, Down to $7
- Men's Glasses
Various of Glasses & Frames For Men
New Cool Men's Glasses
- Cat Eye Glasses
Top Brand & High Quality
New Stylish & Matching Any Outfit
- Calhoun US $25.95
View the Pricing Of the Calhoun
Eyeglass And Select Lenses.
- $7 Glasses Frames
Flash sale, up to 76% off
High quality & stylish
- Men's Glasses
Search results
Jul 6, 2016 · P.D. Shenoy, former managing director of the Karnataka State Road Transport Corporation (KSRTC), has said that he had focused on cost effective management of “four M’s” — manpower, money ...
Jun 30, 2016 · Former IAS officer Dr. P. D. Shenoy who had been popularly known as turnaround specialist of public sector units (PSUs) spoke recently to the students and faculty member of the School of Management of Manipal on how he had turned around the fortunes of the Karnataka State Road Transport Corporation (KSRTC), which had made losses continuously for 13 years until he became its Managing Director ...
Feb 21, 2017 · February 21, 2017 - By Elizabeth Svoboda. Electrical engineer Krishna Shenoy began dreaming of developing a brain-controlled implant before coming to Stanford in 2001. Billions of text messages and emails are sent around the globe each day. One seldom if ever pauses to think about the complex interplay of neurons, synapses and muscles at work ...
3 days ago · “Both nivolumab and pembrolizumab are antibodies directed against PD-1, and based on these other studies, we expected to achieve positive results with the AMBASSADOR trial,” says Dr. Sonpavde. In this latest trial, 702 patients underwent randomization with 354 assigned to receive pembrolizumab and 348 to observation.
Through this research, we expect to identify new regulatory mechanisms implicated in PD, potentially identifying novel drug targets for treatment. The impact of this research could significantly advance our understanding of PD and pave the way for innovative therapeutic strategies.” Meet more Parkinson’s researchers!
6 days ago · Nicolas Girard, MD, PhD, discusses the rationale of targeting PD-L1 and LAG-3 in NSCLC in the RELATIVITY-104 study. The phase 2 RELATIVITY-104 study (NCT04623775) aimed to evaluate the effectiveness of a combination therapy involving nivolumab and relatlimab (Odualag), and platinum doublet chemotherapy as a first-line treatment for metastatic non–small cell lung cancer (NSCLC).
People also ask
Who is Dr Shenoy?
Who is Dr. Anand Shenoy?
What services does Dr. Shenoy provide?
Who is Dev Shenoy?
What did Dr Shenoy do before joining OUSD (R&E)?
What did Dr Shenoy do before serving at OSD/MIBP?
Dr. Dev Shenoy joined the Office of the Under Secretary of Defense for Research and Engineering, OUSD(R&E), as the Principal Director for Microelectronics in July 2021. In this role, Dr. Shenoy is
